Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

B-cells in multiple sclerosis.

M Duddy1, A Bar-Or

  • 1Department of Neurology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle-upon-Tyne, UK. martin.duddy@nuth.nhs.uk

International MS Journal
|November 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter Automated Central Vein Sign Detection Performs as Well as Manual Assessment for the Diagnosis of Multiple Sclerosis.

AJNR. American journal of neuroradiology·2024
Same author

Stick or twist? Cost-effectiveness of siponimod compared with continuing existing disease-modifying therapies in the treatment of active secondary progressive multiple sclerosis in the UK.

Journal of medical economics·2022
Same author

Modified Delphi study of decision-making around treatment sequencing in relapsing-remitting multiple sclerosis.

European journal of neurology·2020
Same author

Management of pancreaticoduodenal artery aneurysm associated with coeliac artery stenosis.

Annals of the Royal College of Surgeons of England·2019
Same author

Factors Affecting Medium-Term Outcomes After Crural Angioplasty in Critically Ischemic Legs.

Vascular and endovascular surgery·2015
Same author

High false-positive rate of questionnaire-based restless legs syndrome diagnosis in multiple sclerosis.

Sleep medicine·2015
Same journal

American academy of neurology annual meeting.

International MS journal·2011
Same journal

Tumour Necrosis Factor Neutralization in MS: A Cautionary Tale.

International MS journal·2011
Same journal

The clinical usefulness of routine MRI assessment.

International MS journal·2011
Same journal

Acute Psychosis as the Initial Presentation of MS: A Case Report.

International MS journal·2011
Same journal

Russell Brains Review of MS.

International MS journal·2011
Same journal

Epstein-Barr Virus and MS:Causality or Association?

International MS journal·2011
See all related articles

B-cells play a crucial role in multiple sclerosis (MS) pathogenesis, from initial antigen capture to tissue repair. Targeting B-cell functions offers a promising avenue for future MS treatment strategies.

Area of Science:

  • Immunology
  • Neuroscience
  • Pathology

Background:

  • B-cells are implicated in various stages of Multiple Sclerosis (MS) pathogenesis.
  • Their roles span from antigen presentation and immune response regulation to antibody secretion.
  • Dysregulation of B-cell functions is increasingly recognized in MS pathology.

Purpose of the Study:

  • To review recent advances in B-cell biology and their abnormal regulation in MS.
  • To discuss the potential of targeting B-cells for MS treatment.

Main Methods:

  • Literature review of current research on B-cell biology and MS.
  • Analysis of existing and potential therapeutic strategies targeting B-cells.

Main Results:

Related Experiment Videos

  • B-cells are involved in antigen capture, tissue damage, and repair processes in MS.
  • Current MS treatments may exert efficacy by targeting B-cell responses.
  • Specific anti-B-cell therapies are under investigation.

    • Conclusions:

    • Targeting B-cells, including their roles as antigen-presenting cells, immune regulators, or antibody-secreting cells, is a key area for future MS therapeutic development.
    • Even with limited success, B-cell-focused strategies are likely to be part of future effective MS treatments.